The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Cellular immune response to HTLV-1
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nagai, M., Usuku, K., Matsumoto, W., Kodama, D., Takenouchi, N., Moritoyo, T., Hashiguchi, S., Ichinose, M., Bangham, C. R., Izumo, S., et al. (1998) · Journal of Neurovirology · doi:10.3109/13550289809114225 · Cited by 694 · cited 10×
“Evidence was obtained in Japan (Fujihara et al., 1991; Yu et al., 1991) that patients with HAM/TSP had both lower frequency and a lower activity of NK cells (especially the CD3þ CD16þ subset) than did asymptomatic HTLV-1 carriers, although the results were not normalized with respect to the proviral load.”
BackgroundInfluentialSelf-citationJeffery, K. J. M., Usuku, K., Hall, S. E., Matsumoto, W., Taylor, G. P., Procter, J., Bunce, M., Ogg, G. S., Welsh, K. I., Weber, J. N., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3848 · Cited by 419
Self-citationHidaka, M., Inoue, J., Yoshida, M., & Seiki, M. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02840.x · Cited by 280 · cited 2×
“Recently, possible molecular mechanisms for such suppression of Tax expression have been identified, including both HTLV-1 factors – Rex (Hidaka et al., 1988), the pX protein p30 II (Nicot et al., 2004) and HBZ (Gaudray et al., 2002) – and host factors – histone deacetylases (Lemasson et al., 2004) and GLI-2/THP (Smit…”
Background
Cited by
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation
Matsuoka, M., & Jeang, K.-T. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2111 · Cited by 829
Dougan, M., & Dranoff, G. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132544 · Cited by 607
Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases
Gonçalves, D. U., Proietti, F. A., Ribas, J. G. R., Araújo, M. G., Pinheiro, S. R., Guedes, A. C., & Carneiro-Proietti, A. B. F. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00063-09 · Cited by 478
Gillet, N. A., Malani, N., Melamed, A., Gormley, N., Carter, R., Bentley, D., Berry, C., Bushman, F. D., Taylor, G. P., & Bangham, C. R. M. (2011) · Blood · doi:10.1182/blood-2010-10-312926 · Cited by 316
Self-citationHTLV-1-associated myelopathy/tropical spastic paraparesis
Bangham, C. R. M., Araujo, A., Yamano, Y., & Taylor, G. P. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.12 · Cited by 279
Self-citationSaito, M., Matsuzaki, T., Satou, Y., Yasunaga, J.-I., Saito, K., Arimura, K., Matsuoka, M., & Ohara, Y. (2009) · Retrovirology · doi:10.1186/1742-4690-6-19 · Cited by 184
“Although the factors that cause these different manifestations of HTLV-1 infection are not fully understood, previous population association studies suggested that both viral and host genetic factors influence the outcome of infection [12].”
BackgroundAlteration of Blood–Brain Barrier Integrity by Retroviral Infection
Afonso, P. V., Ozden, S., Cumont, M.-C., Seilhean, D., Cartier, L., Rezaie, P., Mason, S., Lambert, S., Huerre, M., Gessain, A., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000205 · Cited by 112
Miyazato, P., Yasunaga, J.-I., Taniguchi, Y., Koyanagi, Y., Mitsuya, H., & Matsuoka, M. (2006) · Journal of Virology · doi:10.1128/jvi.01009-06 · Cited by 54
“On the other hand, Tax-expressing cells are rapidly eliminated in vivo, since the Tax protein is a major target antigen of cytotoxic T lymphocytes (CTLs) ( 4 , 27).”
Background
Metadata
- Authors
- Bangham, C. R. M., & Osame, M.
- Venue
- Oncogene
- Published
- 2005-09-05
- Volume
- 24
- Issue
- 39
- Pages
- 6035-6046
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2080441045
- Cited by
- 193
- References
- 3
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.